Function and dysfunction of hypocretin/orexin: An energetics point of view

Annual Review of Neuroscience

Volumn 37, Issue , 2014, Pages 101-116

  Gao, Xiao Bing ^a   Horvath, Tamas ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Energy balance; Hypocretin; Hypocretin orexin; Motivational behavior; Orexin; Sleep wake regulation

Indexed keywords

OREXIN; NEUROPEPTIDE; OREXINS; SIGNAL PEPTIDE;

ANIMAL BEHAVIOR; ENERGY BALANCE; ENERGY EXPENDITURE; ENERGY TRANSFER; HUMAN; LATERAL HYPOTHALAMUS; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; REWARD; SLEEP WAKING CYCLE; ANIMAL; AROUSAL; ENERGY METABOLISM; NARCOLEPSY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; AROUSAL; ENERGY METABOLISM; HUMANS; HYPOTHALAMIC AREA, LATERAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOTIVATION; NARCOLEPSY; NEUROPEPTIDES;

EID: 84904699761     PISSN: 0147006X     EISSN: 15454126     Source Type: Book Series    
DOI: 10.1146/annurev-neuro-071013-013855     Document Type: Review

References (152)

1. Adamantidis AR, Zhang F, Aravanis AM, Deisseroth K, de Lecea L. 2007. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 450:420-24
2. Adams WJ, Lorens SA, Mitchell CL. 1972. Morphine enhances lateral hypothalamic self-stimulation in the rat. Proc. Soc. Exp. Biol. Med. 140:770-71
3. Adeghate E, Fernandez-Cabezudo M, Hameed R, El-Hasasna H, ElWasila M, et al. 2010. Orexin-1 receptor co-localizes with pancreatic hormones in islet cells andmodulates the outcome of streptozotocin-induced diabetes mellitus. PLoS ONE 5(1):e8587
4. Akinnusi ME, Saliba R, Porhomayon J, El-Solh AA. 2012. Sleep disorders in morbid obesity. Eur. J. Intern. Med. 23(3):219-26
5. Anand BK, Brobeck JR. 1951a.Hypothalamic control of food intake in rats and cats. Yale J. Biol.Med. 24:123-40
6. Anand BK, Brobeck JR. 1951b. Localization of a "feeding center" in the hypothalamus of the rat. Proc. Soc. Exp. Biol. Med. 77:323-24
7. Asakawa A, Inui A, Goto K, Yuzuriha H, Takimoto Y, et al. 2002. Effects of agouti-related protein, orexin and melanin-concentrating hormone on oxygen consumption in mice. Int. J. Mol. Med. 10:523-25
8. Baimel C, Borgland SL. 2012. Hypocretin modulation of drug-induced synaptic plasticity. Prog. Brain Res. 198:123-31
9. Baldo BA, Gual-Bonilla L, Sijapati K, Daniel RA, Landry CF, Kelley AE. 2004. Activation of a subpopulation of orexin/hypocretin-containing hypothalamic neurons by GABAA receptor-mediated inhibition of the nucleus accumbens shell, but not by exposure to a novel environment. Eur. J. Neurosci. 19:376-86
10. Beck B, Richy S, Dimitrov T, Stricker-Krongrad A. 2001. Opposite regulation of hypothalamic orexin and neuropeptide Y receptors and peptide expressions in obese Zucker rats. Biochem. Biophys. Res. Commun. 286:518-23
11. Benington JH, Heller HC. 1995. Restoration of brain energy metabolism as the function of sleep. Prog. Neurobiol. 45:347-60
12. Blanco-Centurion C, LiuM, Konadhode R, Pelluru D, Shiromani PJ. 2013. Effects of orexin gene transfer in the dorsolateral pons in orexin knockout mice. Sleep 36(1):31-40
13. Borgland SL, Chang S-J, Bowers MS, Thompson J, Vittoz N, et al. 2009. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J. Neurosci. 29:11215-25
14. Borgland SL, Taha SA, Sarti F, Fields HL, Bonci A. 2006. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49:589-601
15. Bourgin P, Huitr on-Resendiz S, Spier AD, Fabre V, Morte B, et al. 2000. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J. Neurosci. 20:7760-65
16. Boutrel B, Kenny PJ, Specio SE, Martin-Fardon R, Markou A, et al. 2005. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc. Natl. Acad. Sci. USA 102:19168-73
17. Boyle PJ, Scott JC, Krentz AJ, Nagy RJ,Comstock E,Hoffman C. 1994. Diminished brain glucosemetabolism is a significant determinant for falling rates of systemic glucose utilization during sleep in normal humans. J. Clin. Invest. 93:529-35
18. Burdakov D, Jensen LT, Alexopoulos H, Williams RH, Fearon IM, et al. 2006. Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose. Neuron 50(5):711-22
19. Burt J, Alberto CO, ParsonsMP, Hirasawa M. 2011. Local network regulation of orexin neurons in the lateral hypothalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301(3):R572-80
20. Cai XJ, Evans ML, Lister CA, Leslie RA, Arch JRS, et al. 2001. Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin-B levels. Responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract. Diabetes 50:105-12
21. Cai XJ, Lister CA, Buckingham RE, Pickavance L, Wilding J, et al. 2000. Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone. Brain Res. Mol. Brain Res. 77:131-37
22. Cai XJ, Widdowson PS, Harrold J, Wilson S, Buckingham RE, et al. 1999. Hypothalamic orexin expression: modulation by blood glucose and feeding. Diabetes 48:2132-37
23. Camfferman D, McEvoy RD, ODonoghue F, Lushington K. 2008. Prader Willi Syndrome and excessive daytime sleepiness. Sleep Med. Rev. 12:65-75
24. Carr KD. 2011. Food scarcity, neuroadaptations, and the pathogenic potential of dieting in an unnatural ecology: binge eating and drug abuse. Physiol. Behav. 104:162-67
25. Carroll ME, France CP, Meisch RA. 1979. Food deprivation increases oral and intravenous drug intake in rats. Science 205:319-21
26. Cazala P, Darracq C, Saint-Marc M. 1987. Self-administration of morphine into the lateral hypothalamus in the mouse. Brain Res. 416:283-88
27. Chandra R, Liddle RA. 2009. Neural and hormonal regulation of pancreatic secretion. Curr. Opin. Gastroenterol. 25:441-46
28. Chemelli RM,Willie JT, Sinton CM, Elmquist JK, Scammell T, et al. 1999. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98:437-51
29. Davis SF, Williams KW, Xu W, Glatzer NR, Smith BN. 2003. Selective enhancement of synaptic inhibition by hypocretin (orexin) in rat vagal motor neurons: implications for autonomic regulation. J. Neurosci. 23:3844-54
30. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, et al. 1998. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA 95:322-27
31. de Lecea L, Sutcliffe JG. 2005. The hypocretins and sleep. FEBS J. 272:5675-88
32. Delgado J, Anand BK. 1953. Increase of food intake induced by electrical stimulation of the lateral hypothalamus. Am. J. Physiol. 172:162-68
33. Dube MG, Kalra SP, Kalra PS. 1999. Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action. Brain Res. 842:473-77
34. Espana RA. 2012. Hypocretin/orexin involvement in reward and reinforcement. Vitam. Horm. 89:185-208
35. Espana RA, Baldo BA, Kelley AE, Berridge CW. 2001. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 106:699-715
36. Espana RA, Melchior JR, Roberts DC, Jones SR. 2011. Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration. Psychopharmacology 214:415-26
37. Espana RA,Oleson EB, Locke JL, Brookshire BR, RobertsDC, Jones SR. 2010. The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. Eur. J. Neurosci. 31:336-48
38. Estabrooke IV, McCarthy MT, Ko E, Chou TC, Chemelli RM, et al. 2001. Fos expression in orexin neurons varies with behavioral state. J. Neurosci. 21:1656-62
39. Fronczek R, Lammers GJ, Balesar R,Unmehopa UA, Swaab DF. 2005. The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 90(9):5466-70
40. Fujiki N, Yoshida Y, Ripley B, Honda K, Mignot E, Nishino S. 2001. Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation. Neuroreport 17:993-97
41. GeorgescuD,ZachariouV, BarrotM,Mieda M, Willie JT, et al. 2003. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J. Neurosci. 23:3106-11
42. Goodall EB, Carey RJ. 1975. Effects of D- versus L-amphetamine, food deprivation, and current intensity on self-stimulation of the lateral hypothalamus, substantia nigra, and medial frontal cortex of the rat. J. Comp. Physiol. Psychol. 89:1029-45
43. Griffond B, Risold PY, Jacquemard C, Colard C, Fellman D. 1999. Insulin-induced hypoglycemia increases prehypocretin (orexin) mRNA in the rat lateral hypothalamic area. Neurosci. Lett. 262:77-80
44. Guan JL, Uehara K, Lu S, Wang QP, Funahashi H, et al. 2002. Reciprocal synaptic relationships between orexin- and melanin-concentrating hormone-containing neurons in the rat lateral hypothalamus: a novel circuit implicated in feeding regulation. Int. J. Obes. Relat. Metab. Disord. 26(12):1523-32
45. Guilleminault C, Carskadon M, Dement WC. 1974. On the treatment of rapid eye movement narcolepsy. Arch. Neurol. 30:90-93
46. Guyon A, Tardy MP, Rovere C, Nahon JL, Barhanin J, Lesage F. 2009. Glucose inhibition persists in hypothalamic neurons lacking tandem-pore K+ channels. J. Neurosci. 29(8):2528-33
47. Hagan JJ, Leslie RA, Patel S, EvansML, Wattam TA, et al. 1999. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. USA 96:10911-16
48. Hamlin AS, Clemens KJ,McNally GP. 2008. Renewal of extinguished cocaine-seeking. Neuroscience 151:659-70
49. Han F. 2012. Sleepiness that cannot be overcome: narcolepsy and cataplexy. Respirology 17(8):1157-65
50. Hara J, Beuckmann CT, Nambu T,Willie JT, Chemelli RM, et al. 2001. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30(2):345-54
51. Harris GC, Wimmer M, Aston-Jones G. 2005. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437(7058):556-59
52. Haynes AC, JacksonB,Chapman H, TadayyonM, Johns A, et al. 2000.Aselective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul. Pept. 96:45-51
53. Heinonen MV, Purhonen AK,Makela KA, Herzig KH. 2008. Functions of orexins in peripheral tissues. Acta Physiol. 192:471-85
54. Hetherington AW, Ranson SW. 1940. Hypothalamic lesions and adiposity in the rat. Anat. Rec. 78:149-72
55. Himmi T, Boyer A, Orsini JC. 1988. Changes in lateral hypothalamic neuronal activity accompanying hyperand hypoglycemias. Physiol. Behav. 44:347-54
56. Ho CY, Berridge KC. 2013. An orexin hotspot in ventral pallidum amplifies hedonic liking for sweetness. Neuropsychopharmacology 38(9):1655-64
57. Hollander JA, Lu Q, Cameron MD, Kamenecka TM, Kenny PJ. 2008. Insular hypocretin transmission regulates nicotine reward. Proc. Natl. Acad. Sci. USA 105:19480-85
58. Hollander JA, Pham D, Fowler CD, Kenny PJ. 2012. Hypocretin-1 receptors regulate the reinforcing and reward-enhancing effects of cocaine: pharmacological and behavioral genetics evidence. Front. Behav. Neurosci. 6:47
59. Horvath TL, Diano S, van den Pol AN. 1999. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J Neurosci. 19(3):1072-87
60. HorvathTL, GaoXB. 2005. Input organization and plasticity of hypocretin neurons: possible clues to obesitys association with insomnia. Cell Metab. 1:279-86
61. J ohren O, Gremmels JA, Qadri F, Dendorfer A, Dominiak P. 2006. Adrenal expression of orexin receptor subtypes is differentially regulated in experimental streptozotocin induced type-1 diabetes. Peptides 27:2764-69
62. Kantor S, Mochizuki T, Lops SN, Ko B, Clain E, et al. 2013. Orexin gene therapy restores the timing and maintenance of wakefulness in narcoleptic mice. Sleep 36(8):1129-38
63. Katafuchi T, Oomura Y, Yoshimatsu H. 1985. Single unit activity in the rat lateral hypothalamus during 2-deoxy-D-glucose induced and natural feeding behavior. Brain Res. 359:1-9
64. Kenny PJ. 2011.Common cellular andmolecular mechanisms in obesity and drug addiction. Nat. Rev. Neurosci. 12(11):638-51
65. Kiwaki K, Kotz CM,Wang C, Lanningham-Foster L, Levine JA. 2004. Orexin A (hypocretin 1) injected into hypothalamic paraventricular nucleus and spontaneous physical activity in rats. Am. J. Physiol. Endocrinol. Metab. 286:E551-59
66. Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE. 2003. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J. Neurosci. 23:7-11
67. Kotz C, Nixon J, Butterick T, Perez-Leighton C, Teske J, Billington C. 2012. Brain orexin promotes obesity resistance. Ann. N. Y. Acad. Sci. 1264(1):72-86
68. Kotz CM, Teske JA, Billington CJ. 2008. Neuroregulation of nonexercise activity thermogenesis and obesity resistance. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294:R699-710
69. Kotz CM, Teske JA, Levine JA, Wang C. 2002. Feeding and activity induced by orexin A in the lateral hypothalamus in rats. Regul. Pept. 104:27-32
70. Kotz CM,Wang C, Teske JA, Thorpe AJ, Novak CM, et al. 2006. Orexin A mediation of time spent moving in rats: neural mechanisms. Neuroscience 142:29-36
71. Krowicki ZK, Burmeister MA, Berthoud HR, Scullion RT, Fuchs K, Hornby PJ. 2002. Orexins in rat dorsal motor nucleus of the vagus potently stimulate gastric motor function. Am. J. Physiol. Gastrointest. Liver Physiol. 283:G465-72
72. Kurose T, Ueta Y, Yamamoto Y, Serino R, Ozaki Y, et al. 2002. Effects of restricted feeding on the activity of hypothalamic Orexin (OX)-A containing neurons and OX2 receptor mRNA level in the paraventricular nucleus of rats. Regul. Pept. 104:145-51
73. Lee MG, Hassani OK, Jones BE. 2005. Discharge of identified orexin/hypocretin neurons across the sleepwaking cycle. J. Neurosci. 25:6716-20
74. LeSage MG, Perry JL, Kotz CM, Shelley D, Corrigall WA. 2010. Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA. Psychopharmacology 209:203-12
75. Lin JS, Sakai K, Vanni-Mercier G, Jouvet M. 1989. A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats. Brain Res. 479:225-40
76. Lin L, Faraco J, Li R, Kadotani H, Rogers W, et al. 1999. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98(3):365-76
77. Liu Z-W,Gan G, Suyama S, Gao X-B. 2011. Intracellular energy status regulates activity in hypocretin/orexin neurones: a link between energy and behavioural states. J. Physiol. 589(Pt. 17):4157-66
78. Liu Z-W, Gao X-B. 2007. Adenosine inhibits activity of hypocretin/orexin neurons by the A1 receptor in the lateral hypothalamus: a possible sleep-promoting effect. J. Neurophysiol. 97(1):837-48
79. Lopez M, Seoane L, Garcia MC, Lago F, Casanueva FF, et al. 2000. Leptin regulation of prepro-orexin and orexin receptor mRNA levels in the hypothalamus. Biochem. Biophys. Res. Commun. 269(1):41-45
80. Lubkin M, Stricker-Krongrad A. 1998. Independent feeding and metabolic actions of orexins inmice. Biochem. Biophys. Res. Commun. 253(2): 241-45
81. Mackiewicz M, Naidoo N, Zimmerman JE, Pack AI. 2008. Molecular mechanisms of sleep and wakefulness. Ann. N. Y. Acad. Sci. 1129:335-49
82. Mahler SV, Smith RJ, Moorman DE, Sartor GC, Aston-Jones G. 2012. Multiple roles for orexin/hypocretin in addiction. Prog. Brain Res. 198:79-121
83. Mahlios J,De laHerran-Arita AK, MignotE. 2013.The autoimmune basis of narcolepsy. Curr. Opin.Neurobiol. 23:767-73
84. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, et al. 2001. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435(1):6-25
85. McPhersonCS, FeatherbyT,KrstewE,Lawrence AJ. 2007. Quantification of phosphorylated cAMP-response element-binding protein expression throughout the brain of amphetamine-sensitized rats: activation of hypothalamic orexin A-containing neurons. J. Pharmacol. Exp. Ther. 323:805-12
86. Mileykovskiy BY, Kiyashchenko LI, Siegel JM. 2005. Behavioral correlates of activity in identified hypocretin/ orexin neurons. Neuron 46:787-98
87. Mondal MS, NakazatoM, Date Y,Murakami N, YanagisawaM,Matsukura S. 1999. Widespread distribution of orexin in rat brain and its regulation upon fasting. Biochem. Biophys. Res. Commun. 256(3):495-99
88. Moriguchi T, Sakurai T, Nambu T, Yanagisawa M, Goto K. 1999. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia. Neurosci. Lett. 264:101-4
89. NautaWJH. 1946. Hypothalamic regulation of sleep in rats: an experimental study. J. Neurophysiol. 9:285-316
90. Nevsimalova S, Vankova J, Stepanova I, Seemanova E, Mignot E, Nishino S. 2005. Hypocretin deficiency in Prader-Willi syndrome. Eur. J. Neurol. 12(1):70-72
91. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. 2000. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355:39-40
92. Olds J. 1958. Self-stimulation of the brain; its use to study local effects of hunger, sex, and drugs. Science 127:315-24
93. Olds J, Milner P. 1954. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J. Comp. Physiol. Psychol. 47:419-27
94. Olds ME, Williams KN. 1980. Self-administration of D-Ala2-Met- enkephalinamide at hypothalamic selfstimulation sites. Brain Res. 194:155-70
95. Paranjape S, Vavaiya K, Kale A, Briski K. 2007. Role of dorsal vagal motor nucleus orexin-receptor-1 in glycemic responses to acute versus repeated insulin administration. Neuropeptides 41:111-16
96. ParsonsMP, Hirasawa M. 2010. ATP-sensitive potassium channel-mediated lactate effect on orexin neurons: implications for brain energetics during arousal. J. Neurosci. 30(24):8061-70
97. Pasumarthi RK, Reznikov LR, Fadel J. 2006. Activation of orexin neurons by acute nicotine. Eur. J. Pharmacol. 535:172-76
98. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, et al. 1998. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18:9996-10015
99. Plaza-Zabala A, Flores A ,Maldonado R, Berrendero F. 2011.Hypocretin/ orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal. Biol. Psychiatry 71:214-23
100. Porkka-Heiskanen T, Kalinchuk AV. 2011. Adenosine, energy metabolism and sleep homeostasis. Sleep Med. Rev. 15(2):123-35
101. Ranson SW. 1939. Somnolence caused by hypothalamic lesions in the monkey. Arch.Neurol. Psychiatry 41:1-23
102. Rao Y, Lu M, Ge F, Marsh DJ, Qian S, et al. 2008. Regulation of synaptic efficacy in hypocretin/orexincontaining neurons by melanin concentrating hormone in the lateral hypothalamus. J. Neurosci. 28(37):9101-10
103. Rao Y, Mineur YS, Gan G, Wang AH, Liu ZW, et al. 2013. Repeated in vivo exposure of cocaine induces long-lasting synaptic plasticity in hypocretin/orexin-producing neurons in the lateral hypothalamus in mice. J. Physiol. 591:1951-66
104. Ripley B, Overeem S, Fujiki N, Nevsimalova S, Uchino M, et al. 2001. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 57:2253-58
105. Rodgers RJ, Ishii Y, Halford JC, Blundell JE. 2002. Orexins and appetite regulation. Neuropeptides 36:303-25
106. Sakurai T. 2005. Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis. Sleep Med. Rev. 9:231-41
107. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, et al. 1998. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573-85
108. SamsonWK, Taylor MM, Ferguson AV. 2005. Non-sleep effects of hypocretin/orexin. Sleep Med. Rev. 9:243-52
109. Saper CB. 2006. Staying awake for dinner: hypothalamic integration of sleep, feeding, and circadian rhythms. Prog. Brain Res. 153:243-52
110. Saper CB. 2013. The neurobiology of sleep. Continuum 19(1 Sleep Disord.):19-31
111. Sawchenko PE. 1998. Toward a new neurobiology of energy balance, appetite, and obesity: the anatomists weigh in. J. Comp. Neurol. 402:435-41
112. Scharf MT, Naidoo N, Zimmerman JE, Pack AI. 2008. The energy hypothesis of sleep revisited. Prog. Neurobiol. 86:264-80
113. Schuld A, Hebebrand J,Geller F, Pollmacher T. 2000. Increased body-mass index in patients with narcolepsy. Lancet 355:1274-75
114. Selbach O, Haas HL. 2006. Hypocretins: the timing of sleep and waking. Chronobiol. Int. 23(1-2):63-70
115. Sellayah D, Bharaj P, Sikder D. 2011. Orexin is required for brown adipose tissue development, differentiation, and function. Cell Metab. 14:478-90
116. Sellayah D, Sikder D. 2012. Orexin receptor-1 mediates brown fat developmental differentiation. Adipocyte 1:58-63
117. Semjonous NM, Smith KL, Parkinson JR,Gunner DJ, Liu YL, et al. 2009. Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balance. Int. J. Obes. 33:775-85
118. Shiuchi T, Haque MS, Okamoto S, Inoue T, Kageyama H, et al. 2009. Hypothalamic orexin stimulates feeding-associated glucose utilization in skeletal muscle via sympathetic nervous system. Cell Metab. 10:466-80
119. Shulman RG, Hyder F, Rothman DL. 2003. Cerebral metabolism and consciousness. C. R. Biol. 326:253-73
120. Shulman RG, Hyder F, Rothman DL. 2009. Baseline brain energy supports the state of consciousness. Proc. Natl. Acad. Sci. USA 106:11096-101
121. Shulman RG, Rothman DL, Hyder F. 1999. Stimulated changes in localized cerebral energy consumption under anesthesia. Proc. Natl. Acad. Sci. USA 96:3245-50
122. Stellar E. 1954. The physiology of motivation. Psychol. Rev. 61:5-22
123. Stricker EM, Swerdloff AF, Zigmond MJ. 1978. Intrahypothalamic injections of kainic acid produce feeding and drinking deficits in rats. Brain Res. 158:470-73
124. Stricker-Krongrad A, Richy S, Beck B. 2002. Orexins/hypocretins in the ob/ob mouse: hypothalamic gene expression, peptide content and metabolic effects. Regul. Pept. 104:11-20
125. Sutcliffe JG, de Lecea L. 2002. The hypocretins: setting the arousal threshold. Nat. Rev. Neurosci. 3:339-49
126. Swett C, Hobson J. 1968. The effects of posterior hypothalamic lesions on behavioral and electrographic manifestations of sleep and waking in cats. Arch. Ital. Biol. 106:283-93
127. Szekely M. 2006. Orexins, energy balance, temperature, sleep-wake cycle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291:R530-32
128. Takahashi N, Okumura T, Yamada H, Kohgo Y. 1999. Stimulation of gastric acid secretion by centrally administered orexin-A in conscious rats. Biochem. Biophys. Res. Commun. 254:623-27
129. Teske JA, Billington CJ, Kotz CM. 2010. Hypocretin/orexin and energy expenditure. Acta Physiol. 198:303-12
130. Thannickal TC,MooreRY, Nienhuis R, Ramanathan L, Gulyani S, et al. 2000. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469-74
131. Thorpe AJ, Mullett MA, Wang C, Kotz CM. 2003. Peptides that regulate food intake: regional, metabolic, and circadian specificity of lateral hypothalamic orexin A feeding stimulation.Am. J. Physiol. Regul. Integr. Comp. Physiol. 284:R1409-17
132. Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LH, Guan XM. 1998. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett. 438(1-2):71-75
133. Tsuneki H, Wada T, Sasaoka T. 2010. Role of orexin in the regulation of glucose homeostasis. Acta Physiol. 198:335-48
134. Tupone D,Madden CJ, Cano G, Morrison SF. 2011. An orexinergic projection from perifornical hypothalamus to raphe pallidus increases rat brown adipose tissue thermogenesis. J. Neurosci. 31:15944-55
135. Ungerstedt U. 1971. Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. 367:95-122
136. van den Pol AN. 1999. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J. Neurosci. 19:3171-82
137. van den Pol AN, Acuna-Goycolea C, Clark KR, Ghosh PK. 2004. Physiological properties of hypothalamic MCH neurons identified with selective expression of reporter gene after recombinant virus infection. Neuron 42(4):635-52
138. van den PolAN, GaoX-B,ObrietanK,Kilduff T,Belousov AB. 1998. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J. Neurosci. 18:7962-71
139. van den PolAN, Ghosh PK, LiuRJ, Li Y, Aghajanian GK,Gao XB. 2002. Hypocretin (orexin) enhances neuron activity and cell synchrony in developing mouse GFP-expressing locus coeruleus. J. Physiol. 541:169-85
140. von Economo C. 1930. Sleep as a problem of localization. J. Nerv. Ment. Dis. 71:249-59
141. Vyazovskiy VV, Cirelli C, Tononi G, Tobler I. 2008. Cortical metabolic rates asmeasured by 2-deoxyglucoseuptake are increased after waking and decreased after sleep in mice. Brain Res. Bull. 75:591-97
142. Wang J, Osaka T, Inoue S. 2003. Orexin-A-sensitive site for energy expenditure localized in the arcuate nucleus of the hypothalamus. Brain Res. 971:128-34
143. Willie JT, Chemelli RM, Sinton CM, Tokita S, Williams SC, et al. 2003. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice:molecular genetic dissection of non-REM andREMsleep regulatory processes. Neuron 38(5):715-30
144. Winrow CJ, Renger JJ. 2013. Discovery and development of orexin receptor antagonists as therapeutics for insomnia. Br. J. Pharmacol. 171:283-93
145. Winrow CJ, Tanis KQ, Reiss DR, Rigby AM, Uslaner JM, et al. 2010. Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure. Neuropharmacology 58:185-94
146. Yamamoto Y, Ueta Y, Serino R, Nomura M, Shibuya I, Yamashita H. 2000. Effects of food restriction on the hypothalamic prepro-orexin gene expression in genetically obese mice. Brain Res. Bull. 51:515-21
147. Yamanaka A, BeuckmannCT, Willie JT,Hara J,Tsujino N, et al. 2003. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 38(5):701-13
148. Yerkes RM, Dodson JD. 1908. The relation of strength of stimulus to rapidity of habit-formation. J. Comp. Neurol. Psychol. 18:459-82
149. Yi CX, Serlie MJ, Ackermans MT, Foppen E, Buijs RM, et al. 2009. A major role for perifornical orexin neurons in the control of glucose metabolism in rats. Diabetes 58:1998-2005
150. Yoshida K, McCormack S, Espana RA, Crocker A, Scammell TE. 2006. Afferents to the orexin neurons of the rat brain. J. Comp. Neurol. 494:845-61
151. Yoshida Y, FujikiN,Nakajima T, Ripley B,Matsumura H, et al. 2001. Fluctuation of extracellular hypocretin- 1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities. Eur. J. Neurosci. 14:1075-81
152. Zeitzer JM, Buckmaster CL, Parker KJ, Hauck CM, Lyons DM, Mignot E. 2003. Circadian and homeostatic regulation of hypocretin in a primatemodel: implications for the consolidation of wakefulness. J. Neurosci. 23:3555-60